Laurion Capital Management LP
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1390202
NEW YORK, NY
Position in ARWR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$320,252
-$1,810,808 QoQ
Shares Held
3,929
-95.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#341
of 497 holders
Holding Since
Jun 2022
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Laurion Capital Management LP holds $278,142,488 across 19 Biotechnology names. ARWR ranks #16 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,352,234 | $100,714,388 | |
| 2 | MLYS |
Mineralys Therapeutics, Inc.
|
2,506,152 | $67,615,980 | |
| 3 | NUVB |
Nuvation Bio Inc.
|
7,820,013 | $44,417,673 | |
| 4 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
2,002,701 | $15,260,581 | |
| 5 | PYXS |
Pyxis Oncology, Inc.
|
4,900,888 | $14,751,672 | |
| 6 | IMUX |
Immunic, Inc.
|
610,326 | $9,380,710 | |
| 7 | AARD |
Aardvark Therapeutics, Inc.
|
1,034,459 | $5,958,483 | |
| 8 | AUTL |
Autolus Therapeutics plc
|
3,316,626 | $5,306,601 |
All Filings in ARWR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $320,252 | 3,929 | Shares | Sole | 2026-08-13 | |
| 2023-03-31 | $2,131,060 | 83,900 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,402,984 | 83,900 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,779,339 | 84,095 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,997,356 | 85,128 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||